← TagsProduct

Opteon

33 articles

Class Action Lawsuit Filed Against Chemours Co (NYSE:CC)

Chemours Co faces a securities class action lawsuit alleging fraud over overstated Opteon product demand and unreliable 2026 financial guidance. Investors are being encouraged to seek recovery for los

ACCESS Newswire · 2026-10-22 14:30